Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
G1 Therapeutics Inc (GTHX)
NASDAQ:GTHX
G1 Therapeutics (GTHX) Stock Price & Analysis
1,748 Followers
GTHX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.08 - $8.40
Previous Close$2
Volume1.13M
Average Volume (3M)553.88K
Market Cap
$103.69M
Enterprise Value$65.26M
Total Cash (Recent Filing)$94.35M
Total Debt (Recent Filing)$55.92M
Price to Earnings (P/E)-1.4
Beta1.58
Next Earnings
Feb 21, 2024EPS Estimate
-$0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.47
Shares Outstanding51,843,669
10 Day Avg. Volume613,820
30 Day Avg. Volume553,879
Standard Deviation0.28
R-Squared0.12
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)2.41
Price to Sales (P/S)2.02
Price to Cash Flow (P/CF)-2.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.84
Enterprise Value/Gross Profit1.27
Enterprise Value/Ebitda-1.86
Forecast
1Y Price Target
$9.00Price Target Upside350.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
G1 Therapeutics News
Ownership Overview
0.00% Insiders
9.72% Mutual Funds
8.19% Other Institutional Investors
82.09% Public Companies and
Individual Investors
GTHX FAQ
What was G1 Therapeutics Inc’s price range in the past 12 months?
G1 Therapeutics Inc lowest stock price was $1.08 and its highest was $8.40 in the past 12 months.
What is G1 Therapeutics Inc’s market cap?
Currently, no data Available
When is G1 Therapeutics Inc’s upcoming earnings report date?
G1 Therapeutics Inc’s upcoming earnings report date is Feb 21, 2024 which is in 79 days.
How were G1 Therapeutics Inc’s earnings last quarter?
G1 Therapeutics Inc released its earnings results on Nov 01, 2023. The company reported -$0.35 earnings per share for the quarter, missing the consensus estimate of -$0.341 by -$0.009.
Is G1 Therapeutics Inc overvalued?
According to Wall Street analysts G1 Therapeutics Inc’s price is currently Undervalued.
Does G1 Therapeutics Inc pay dividends?
G1 Therapeutics Inc does not currently pay dividends.
What is G1 Therapeutics Inc’s EPS estimate?
G1 Therapeutics Inc’s EPS estimate is -$0.27.
How many shares outstanding does G1 Therapeutics Inc have?
G1 Therapeutics Inc has 51,843,670 shares outstanding.
What happened to G1 Therapeutics Inc’s price movement after its last earnings report?
G1 Therapeutics Inc reported an EPS of -$0.35 in its last earnings report, missing expectations of -$0.341. Following the earnings report the stock price went down -18.788%.
Which hedge fund is a major shareholder of G1 Therapeutics Inc?
Among the largest hedge funds holding G1 Therapeutics Inc’s share is Fisher Asset Management LLC. It holds G1 Therapeutics Inc’s shares valued at N/A.
---
G1 Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.00 (350.00% Upside)
$9.00 (350.00% Upside)
Blogger Sentiment
Bullish
GTHX Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 2.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 6.3%
Last 30 Days ▼ 6.3%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.81%
12-Months-Change
Fundamentals
Return on Equity
-158.98%
Trailing 12-Months
Asset Growth
-20.10%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
G1 Therapeutics Inc
G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.
---
Top 5 ETFs holding GTHX
Vanguard Total Stock Market ETF
$2.14M
Up to five ETFs with an Outperform Smart Score that hold GTHX. The ETFs are listed according to market value of GTHX within the ETF
---